The EVAR Center

Filter Your Results




Endologix Announces Recall of Nellix EVAS System, Restricting Use to Prescreened Patients Within Current Indications

January 4, 2019 -- Endologix, Inc. announced a voluntary recall of all existing Nellix endovascular aneurysm sealing (EVAS) system inventory and the stoppage of unrestricted s…

FDA Approves Use of Medtronic's Valiant Navion in Study of Aortica's Case-Planning Technology

December 17, 2018 -- Aortica Corporation announced that the FDA has approved a supplement to an ongoing physician-sponsored investigational device exemption study at the Unive…

Study Evaluates Outcomes of Surgery and EVAR in Obese Versus Nonobese AAA Patients

December 12, 2018 -- The Society for Vascular Surgery (SVS) announced that new research suggests a significant increase in morbidities in obese patients treated for abdominal …

Study Evaluates Relationship of Endologix's Nellix EVAS Device Midterm Results and IFU

December 5, 2018 -- The Society for Vascular Surgery (SVS) announced the publication of findings from a large, single-center experience using the Nellix endovascular aneurysm …

FDA Approves Cordis' InCraft AAA Stent Graft System

November 28, 2018 -- Cordis, a Cardinal Health company, announced FDA approval for the low-profile InCraft abdominal aortic aneurysm (AAA) stent graft system for endovascular …

Three-Year Data From ANCHOR Registry Presented for Medtronic's Heli-FX EndoAnchor System

November 16, 2018 -- Medtronic announced the presentation of data on the Heli-FX EndoAnchor system by William Jordan Jr, MD, at the 45th annual VEITHsymposium held November 13…

Endologix Honors Innovators of Aortic Therapy at VEITHsymposium

November 15, 2018 -- Endologix announced that four innovators of aortic therapy were honored at the 45th annual VEITHsymposium held November 13 -- 17 in New York, New York dur…

Treatment Paradigms for Type B Aortic Dissection–Related Malperfusion and Rupture

Grace J. Wang, MD, MSCE, FACS

November 2018—Assessing the pathophysiology and endovascular treatments for complicated type B aortic dissection with malperfusion or rupture.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.